Evidence map›Paper›PMID 34928235›Full record

ArticleBalkan medical journal2022

Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma

Tuğba Başoğlu, Kadriye Ebru Akar, Pelin Bağcı, Nalan Akgül Babacan, Mehmet Akif Öztürk, Fatih Emin Öztürk, Nazım Can Demircan, Rukiye Arikan, Tuğba Akın Telli, Özlem Ercelep and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Balkan medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Tuğba BaşoğluDepartment of Medical Oncology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0002-2059-5502
Kadriye Ebru AkarDepartment of Pathology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0003-1512-1166
Pelin BağcıDepartment of Pathology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0002-6656-8227
Nalan Akgül BabacanDepartment of Medical Oncology, Bahrain Oncology Center, Al Sayh, BahrainORCID 0000-0001-6006-4290
Mehmet Akif ÖztürkDepartment of Medical Oncology, Bahçeşehir University School of Medicine, İstanbul, TurkeyORCID 0000-0003-1365-7944
Fatih Emin ÖztürkDepartment of Internal Medicine, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0002-8075-7307
Nazım Can DemircanDepartment of Medical Oncology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0001-6630-5278
Rukiye ArikanDepartment of Medical Oncology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0003-2688-1515
Tuğba Akın TelliDepartment of Medical Oncology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0001-6535-6030
Özlem ErcelepDepartment of Medical Oncology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0001-5892-3519
Faysal DaneDepartment of Medical Oncology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0001-6584-902X
Perran Fulden YumukDepartment of Medical Oncology, Marmara University School of Medicine, İstanbul, TurkeyORCID 0000-0001-8650-299X
Marmara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pancreatic ductal adenocarcinoma differs from other solid tumors with its unique immunosuppressive microenvironment and non-immunogenic feature. There are not many studies in the literature investigating the effect of these features on prognosis. Aims: To investigate the prognostic value of tissue-resident memory T cells, tumor microenvironment features, and tumor-associated immune cells in resected pancreatic ductal adenocarcinomas. Study Design: Retrospective cross-sectional study. Methods: Of 138 patients diagnosed with pancreatic ductal adenocarcinoma between 2011 and 2018, 81 were included in the study. Specimens from operated patients were reassessed separately as peritumoral and intratumoral areas for tissue resident memory cells and tumor microenvironmental elements (tumor infiltrating lymphocytes, tumor stroma, CD204+ macrophages, PDL1+ immune cells). Disease-free survival and overall survival were defined from the date of operation to the date of recurrence and the date of first diagnosis to the date of death, respectively. If the patient was alive, the last visit date was taken into account. Results: The median age at diagnosis was 63 (range: 40-78). The median follow-up period was 18.9 months (range: 1.4-80.4 months). Median overall survival was 23.7 months (1.4-80.4 months) and median disease-free survival was 10.8 months (1.4-74.4 months). Patients with higher intra-tumoral tissue-resident memory cell counts had a longer survival trend than those having lower values (25.6 months vs. 18 months, respectively, Conclusion: Tissue-resident memory T cells and other microenvironmental features may be prognostic in resectable pancreatic ductal adenocarcinomas. Further studies with larger cohorts are needed for validation.

Indexed as

AdenocarcinomaPancreatic NeoplasmsCross-Sectional StudiesHumansMemory T CellsPrognosisRetrospective StudiesTumor Microenvironment

Identifiers

PMID34928235
PMCPMC8941239
OpenAlexW3215326277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.